GLULP4

Across TCGA pan-cancer cohorts, GLULP4 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated GLULP4 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher GLULP4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GLULP4 expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

LUAD, UCEC, and SKCM are the cancer types where GLULP4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	II,III,IV	0.622	0.732	.006	46	view →
UCEC	DFS	Tertile	IV	0.838	0.322	<.001	36	view →
SKCM	OS	Tertile	III,IV	0.547	0.274	.004	25	view →
OV	OS	Median	IV	0.779	0.475	.002	24	view →
CESC	OS	Quartile	II,III,IV	0.899	0.600	.004	20	view →
PRAD	DFS	Median	All	0.961	0.909	.006	18	view →
THYM	DFS	Quartile	All	0.802	0.969	.012	12	view →
STAD	OS	Quartile	All	0.612	0.825	.024	11	view →
ESCA	OS	Median	All	1.000	0.659	.020	9	view →
PAAD	OS	Quartile	II,III,IV	0.490	0.744	.022	7	view →
KIRC	DFS	Quartile	IV	0.274	0.531	.036	6	view →
UCS	DFS	Quartile	II,III,IV	0.539	0.166	.011	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

GLULP4–LUAD (DFS)

Open the LUAD breakdown →